VIVEX Biologics

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, VIVEX Biologics sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).

6 total trials 2 currently recruiting upper quartile by trial count

VIVEX Biologics: 6 sponsored US clinical trials, 2 recruiting.

VIVEX Biologics sponsors 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting. The most-studied condition in this pipeline is Disc Degeneration, with 3 trials.

Upper-quartile sponsor footprint

VIVEX Biologics sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

6 total, page 1 of 1

RECRUITING NA

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

NCT06778447
RECRUITING

VIA Disc NP Registry 3.0

NCT06345690
ACTIVE NOT RECRUITING NA

VIA Disc Nucleus Pulposus Older Patients Pilot

NCT05412277
ACTIVE NOT RECRUITING NA

VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs

NCT05201287
TERMINATED NA

Wound Healing Following Penile Prosthesis Implant

NCT05196191
TERMINATED

VIA Disc NP Registry

NCT04652687

Therapeutic Areas

Disc Degeneration 3
Degenerative Disc Disease 3
Low Back Pain 2
Lumbar Discogenic Pain 1
Back Pain, Low 1
Discogenic Pain 1
Back Pain 1

What is open in the VIVEX Biologics pipeline

2 recruiting of 6 indexed (33% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Disc Degeneration (3 trials), 6 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

VIVEX Biologics: open-pipeline peers nationwide

Peers matched on 6 registered trials and 33% open enrollment, not the therapeutic-area sidebar.

VIVEX Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 246810 0%20%40%60%80% Total trials Recruiting share VIVEX Biologics23andMeAardvark TherapeuticsAbbisko Therapeutics CoAbGenomics B.V Taiwan BranchAadi BioscienceAaron CookAbivax S.A.Actuated Medical
VIVEX Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

VIVEX Biologics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 6 trials (± recruiting share)

Sponsors near 33% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this VIVEX Biologics page

6 registered trials is a research-attention snapshot, not an endorsement of VIVEX Biologics or any single study.

  • 2 of VIVEX Biologics's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Disc Degeneration is the condition VIVEX Biologics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Disc Degeneration trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

VIVEX Biologics pipeline card: 6 registered trials from official public datasets.Report a data error.